Tags

Type your tag names separated by a space and hit enter

Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
Psychopharmacology (Berl). 1998 Jul; 138(1):67-75.P

Abstract

MMAI (5-methoxy-6-methyl-2-aminoindan) is a nonneurotoxic, highly selective neuronal serotonin (5-HT) releasing agent. MMAI and other 5-HT releasing agents produce a robust discriminative cue in drug discrimination (DD) studies. The selective serotonin reuptake inhibitors (SSRIs) sertraline and citalopram may also serve as discriminative stimuli, but acquisition of their discrimination required almost twice as much time as for MMAI. In vitro, 5-HT release by MMAI can be blocked by selective SSRIs. However, in the present DD studies, pretreatment with fluoxetine, sertraline, or citalopram 60 min before the training drugs MMAI or (+)-MBDB produced only partial inhibition of the discriminative cue. In substitution tests, sertraline and citalopram partially mimicked the training drugs, whereas only 40% substitution occurred with fluoxetine in MMAI or (+)-MBDB trained rats. In generalization tests, the tricyclic antidepressants imipramine and clomipramine partly substituted for the sertraline, citalopram, and MMAI stimuli. The increase in extracellular 5-HT produced by SSRIs leads to a subtle or feeble drug cue that is apparently difficult for an animal to recognize. This observation contrasts with the 5-HT releasing agents, which clearly produce robust cues that are easily recognized by the animals. However, mechanism(s) responsible for the discriminative stimulus effects of SSRIs and 5-HT releasing agents seem to be similar, at least in part.

Authors+Show Affiliations

Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Purdue University, West Lafayette, IN 47907, USA.No affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

9694528

Citation

Marona-Lewicka, D, and D E. Nichols. "Drug Discrimination Studies of the Interoceptive Cues Produced By Selective Serotonin Uptake Inhibitors and Selective Serotonin Releasing Agents." Psychopharmacology, vol. 138, no. 1, 1998, pp. 67-75.
Marona-Lewicka D, Nichols DE. Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents. Psychopharmacology (Berl). 1998;138(1):67-75.
Marona-Lewicka, D., & Nichols, D. E. (1998). Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents. Psychopharmacology, 138(1), 67-75.
Marona-Lewicka D, Nichols DE. Drug Discrimination Studies of the Interoceptive Cues Produced By Selective Serotonin Uptake Inhibitors and Selective Serotonin Releasing Agents. Psychopharmacology (Berl). 1998;138(1):67-75. PubMed PMID: 9694528.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents. AU - Marona-Lewicka,D, AU - Nichols,D E, PY - 1998/8/7/pubmed PY - 1998/8/7/medline PY - 1998/8/7/entrez SP - 67 EP - 75 JF - Psychopharmacology JO - Psychopharmacology (Berl) VL - 138 IS - 1 N2 - MMAI (5-methoxy-6-methyl-2-aminoindan) is a nonneurotoxic, highly selective neuronal serotonin (5-HT) releasing agent. MMAI and other 5-HT releasing agents produce a robust discriminative cue in drug discrimination (DD) studies. The selective serotonin reuptake inhibitors (SSRIs) sertraline and citalopram may also serve as discriminative stimuli, but acquisition of their discrimination required almost twice as much time as for MMAI. In vitro, 5-HT release by MMAI can be blocked by selective SSRIs. However, in the present DD studies, pretreatment with fluoxetine, sertraline, or citalopram 60 min before the training drugs MMAI or (+)-MBDB produced only partial inhibition of the discriminative cue. In substitution tests, sertraline and citalopram partially mimicked the training drugs, whereas only 40% substitution occurred with fluoxetine in MMAI or (+)-MBDB trained rats. In generalization tests, the tricyclic antidepressants imipramine and clomipramine partly substituted for the sertraline, citalopram, and MMAI stimuli. The increase in extracellular 5-HT produced by SSRIs leads to a subtle or feeble drug cue that is apparently difficult for an animal to recognize. This observation contrasts with the 5-HT releasing agents, which clearly produce robust cues that are easily recognized by the animals. However, mechanism(s) responsible for the discriminative stimulus effects of SSRIs and 5-HT releasing agents seem to be similar, at least in part. SN - 0033-3158 UR - https://www.unboundmedicine.com/medline/citation/9694528/Drug_discrimination_studies_of_the_interoceptive_cues_produced_by_selective_serotonin_uptake_inhibitors_and_selective_serotonin_releasing_agents_ L2 - https://dx.doi.org/10.1007/s002130050646 DB - PRIME DP - Unbound Medicine ER -